View |
BR-1302_PI_01.pdf
|
BR-1302
|
Daratumumab
|
Darzalex
|
20 mg/mL
|
Concentrate For Solution For Infusion (Iv)
|
-
|
Cilag AG
|
Switzerland
|
-
|
01 August 2019
|
01 August 2024
|
View |
|
BR-1303
|
Hepatitis A (Inactivated) Vaccine (Adsorbed)
|
Havrix 720
|
720 ELISA units/0.5 mL
|
Suspension For Injection (IM)
|
-
|
GlazoSmithKlineBiologicals SA
|
Belgium
|
-
|
14 August 2019
|
14 August 2024
|
View |
|
BR-1304
|
Hepatitis A (Inactivated) Vaccine (Adsorbed)
|
Havrix 1440
|
1440 ELISA units/mL
|
Suspension For Injection (IM)
|
-
|
GlazoSmithKlineBiologicals SA
|
Belgium
|
-
|
14 August 2019
|
14 August 2024
|
View |
|
BR-1305
|
Filgrastim
|
None
|
300mcg/0.5mL
|
Solution for Injection (IV/SC)
|
-
|
Hangzhou Jiuyuan Gene Engineering Co., Ltd.
|
China
|
-
|
05 March 2021
|
03 October 2024
|
View |
BR-1306_PI_01.pdf
|
BR-1306
|
Quadrivalent Seasonal Influenza Vaccine (Split
Virion, Inactivated) Southern Hemisphere 2024 Strain
|
Vaxigrip Tetra
|
influenza strains*:
A/Victoria/4897/2022 (H1N1)pdm09-like strain
(A/Victoria/4897/2022, IVR-238)
A/Thailand/8/2022 (H3N2)-like strain
(A/California/122/2022, SAN-022)
15 μg of HA**
15 μg of HA*
***
15 μg of HA**
B/Austria/1359417/2021 (B/Victoria lineage)-like virus
(B/Michigan/01/2021, wild type)
B/Phuket/3073/2013 (B/Yamagata lineage)-like virus
(B/Phuket/3073/2013, wild type)
*Propagated in fertilized hen's eggs from healthy chicken flocks **Haemagglutinin
15 μg of HA**
|
Suspension for Injection (IM/SC)
|
Vaccines
|
Sanofi Pasteur
|
France
|
Monitored Release (Strain Clearance)
|
19 February 2024
|
19 February 2025
|
View |
|
BR-1307
|
Varicella Vaccine (Live, Attenuated)
|
Varilrix
|
Formulation:
After reconstitution, one dose (0.5 mL) contains not less than 103.3 plaque-forming units (PFU) live attenuated varicella-zoster virus (Oka Strain).
|
Lyophilized Powder For Injection (S.C.)
|
Vaccine
|
GlaxoSmithKline Biologicals SA
|
Belgium
|
Initial (Variation)
|
25 July 2023
|
25 July 2028
|
View |
|
BR-1308
|
Pneumococcal Conjugate Vaccine, 13-Valent
|
Prevenar 13
|
0.5 mL per dose
|
Suspension For Im Injection
|
-
|
Pfizer Manufacturing Belgium NV
|
Belgium
|
Initial
|
12 December 2019
|
05 December 2024
|
View |
|
BR-1309
|
Heparin Sodium
|
Heprin
|
1000IU/mL
|
Solution For Injection (Iv/Sc)
|
-
|
Gland Pharma Limited
|
India
|
-
|
17 February 2021
|
30 June 2024
|
View |
|
BR-1310
|
Pneumococcal Polysaccharide And Non-Typeable Haemophilus Influenzae (Nthi) Protein D Conjugate Vaccine, Adsorbed
|
Synflorix
|
0.5mL
|
Suspension For Injection
|
-
|
Glaxosmithkline Biologicals
|
France
|
-
|
21 February 2020
|
22 February 2025
|
View |
BR-1311_PI_01.pdf
|
BR-1311
|
Ustekinumab
|
Stelara
|
130mg/26mL
|
Concentrate for Solution For Infusion (Iv)
|
-
|
Cilag AG
|
Switzerland
|
-
|
02 April 2020
|
02 April 2025
|
View |
BR-1313_PI_01.pdf
|
BR-1313
|
Erenumab
|
Aerinex
|
70 mg/mL
|
Solution For Injection (Sc)
|
-
|
Amgen Manufacturing Limited
|
United States of America
|
Monitored Release
|
09 March 2020
|
09 March 2025
|
View |
|
BR-1315
|
Pneumococcal Polysaccharide Vaccine, Polyvalent
|
Pneumovax 23
|
Each dose (0.5 mL) contains 25 mcg of each polysaccharide type (types 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F, 33F) dissolved in isotonic saline solution containing 0.25% phenol as a preservative.
|
Solution for Injection (I.M./ S.C.)
|
-
|
MSD International GmbH T/A MSD Ireland (Carlow)
|
Ireland
|
-
|
02 April 2020
|
02 April 2025
|
View |
|
BR-1316
|
Trastuzumab
|
Herzuma
|
150mg
|
Powder for Concentrate Solution For Infusion (IV)
|
-
|
Celltrion Inc, Republic of Korea
|
Korea
|
-
|
03 April 2020
|
03 April 2025
|
View |
|
BR-1317
|
Trastuzumab
|
HERZUMA
|
440mg
|
Powder for Concentrate for Solution fro Infusion (IV)
|
-
|
Celltrion Pharm, Inc.
|
Korea
|
-
|
03 April 2020
|
03 April 2025
|
View |
BR-1318_PI_01.pdf
|
BR-1318
|
Follitropin Alfa / Lutropin Alfa
|
Pergoveris
|
350 IU/150 IU (0.48mL)
|
Solution For Injection (SC)
|
-
|
Merck Serono S.p.A.
|
Italy
|
-
|
16 April 2020
|
16 April 2025
|
View |
|
BR-1319
|
Follitropin alfa / Lutropin alfa
|
Pergoveris
|
450 IU/225 IU (0.72 mL)
|
Solution For Injection (SC)
|
-
|
Merck Serono S.p.A
|
Italy
|
Variation
|
11 June 2021
|
16 April 2025
|
View |
|
BR-1320
|
Follitropin alfa / Lutropin alfa
|
Pergoveris
|
900 IU/450 IU (1.44 mL)
|
Solution For Injection (SC)
|
-
|
Merck Serono S.p.A.
|
Italy
|
Variation
|
11 June 2021
|
16 April 2025
|
View |
BR-1321_PI_01.pdf
|
BR-1321
|
Botulinum Toxin Type A
|
Nabota
|
200 Units
|
Lyophilized Powder for Solution for Injection (IM/SC)
|
-
|
Daewoong Pharmaceutical Co., Ltd.
|
Korea
|
Monitored Release
|
16 June 2020
|
16 June 2025
|
View |
BR-1323_PI_01.pdf
|
BR-1323
|
Adalimumab
|
Humira
|
20mg/0.2mL
|
Solution For Injection (SC)
|
-
|
Vetter Pharma-Fertigung GmbH & Co. KG
|
Germany
|
monitored Release
|
24 June 2020
|
24 June 2025
|
View |
BR-1324_PI_01.pdf
|
BR-1324
|
Somatropin
|
Genotropin GoQuick
|
12 mg/mL
|
Powder and Solvent for Solution for Injection (SC)
|
Anterior Pituitary Lobe Hormones and Analogues
|
Pfizer Manufacturing Belgium N.V.
|
Belgium
|
Monitored Release (MR) (Reconstruction) `
|
22 February 2024
|
16 July 2025
|